Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.
Catherine H MieleKristin SchwabRajeev SaggarErin DuffyDavid ElashoffChi-Hong TsengSam WeigtDeepshikha CharanFereidoun AbtinJimmy JohannesAriss DerhovanessianJeffrey ConklinKevin GhassemiDinesh KhannaOsama SiddiquiAbbas ArdehaliCurtis HunterMurray KwonReshma BiniwaleMichelle LoElizabeth VolkmannDavid Torres BarbaJohn A BelperioDavid M SayahThomas MahrerDaniel E FurstSuzanne KafajaPhilip ClementsMichael ShinoAric GregsonBernard KubakJoseph P LynchDavid RossRajan SaggarPublished in: Annals of the American Thoracic Society (2018)
Relative to other lung transplant indications, our SSc group experienced comparable survival, primary graft dysfunction, acute rejection, bronchiolitis obliterans syndrome, and microbiology of respiratory isolates, despite the high prevalence of severe esophageal dysfunction. Esophageal dysfunction rarely precluded active listing for lung transplantation.